Arrowhead Pharmaceuticals Inc

NAS:ARWRHealthcareNASDAQ:NBINASDAQ:NQUSMG

$57.23+2.38%At closeAt close · Tue 20 Oct · ≈ AED 210.18 · Market cap $8.08B · Next earnings Mon 30 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	0.0%	100.0%	95.7%	94.8%	−423.7%	100.0%	—	—
Operating margin	−105.9%	−107.8%	−73.4%	−85.2%	−16,927.1%	11.9%	11.9%	+0.0 pts
Net margin	−96.1%	−101.9%	−72.4%	−85.3%	−16,882.4%	−0.2%	3.6%	+3.8 pts
EBITDA margin	−99.1%	−95.9%	−66.7%	−73.0%	−15,812.8%	19.9%	—	—
Return on equity	−18.3%	−34.5%	−44.2%	−75.7%	−323.3%	−0.3%	6.0%	+6.3 pts
Return on assets	−16.2%	−19.8%	−25.4%	−26.8%	−52.6%	−0.1%	2.2%	+2.3 pts
Return on capital employed	−19.3%	−26.4%	−32.3%	−31.1%	−58.0%	8.3%	—	—
Debt / equity	0.0×	0.1×	0.2×	1.4×	4.6×	0.8×	0.7×	−7.4%
Debt / assets	4.0%	3.6%	11.8%	50.1%	74.7%	26.4%	—	—
Interest coverage	0.0×	0.0×	0.0×	−11.2×	−18.6×	1.1×	—	—
Current ratio	7.9×	2.6×	2.9×	4.0×	6.7×	4.9×	4.9×	+0.0%
Quick ratio	7.8×	2.6×	3.1×	4.0×	6.7×	4.9×	—	—
Cash ratio	3.5×	1.3×	0.8×	1.1×	1.0×	1.2×	1.2×	+0.0%
Asset turnover	0.2×	0.2×	0.4×	0.3×	0.0×	0.6×	—	—
Inventory turnover	0.0×	0.0×	−0.5×	—	—	—	—	—
Receivables turnover	104.0×	13.5×	172.5×	—	—	121.5×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 30 Sep 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.